Evidence map›Paper›PMID 24761016›Full record

ArticleAmerican journal of pharmaceutical education2014

Application of genomic principles to pharmacotherapy of cancer.

Christopher L Farrell, Nancy G Pedigo, Amy R Messersmith

Abstract read
In one paragraph

Article in American journal of pharmaceutical education, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Pharmacogenomics: From classroom to practice.Molecular genetics & genomic medicine · 2018
    Article
  4. Educational strategies to enable expansion of pharmacogenomics-based care.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2016
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher L FarrellSchool of Pharmacy, Presbyterian College, Clinton, South Carolina.
Nancy G PedigoSchool of Pharmacy, Presbyterian College, Clinton, South Carolina.
Amy R MessersmithSchool of Pharmacy, Presbyterian College, Clinton, South Carolina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo teach first-year (P1) pharmacy students to apply the principles of pharmacogenomics underlying clinical pharmacotherapeutics to cancer patients.

designUsing polymerase chain reaction (PCR) and high-resolution melting analysis of deoxyribonucleic acid (DNA) from colorectal cancer cell lines to determine the presence of somatic mutations for an oncogenic marker, students formulated the proper course of treatment for a patient with similar tumor genomics. ASSESSMENT: In a postintervention survey, students highly rated the effectiveness of the laboratory session for learning pharmacogenomics, and subsequent examination scores reflected retention of principles and understanding of clinical application.

conclusionThe pharmacogenomic laboratory exercise prepared students to understand how genetic markers give clinical insight into the appropriate application of drugs in oncology pharmacotherapy. Further, the session inspired their interest in learning more about pharmacogenomics and their professional roles in personalized medicine.

Indexed as

AdultAgedAged, 80 and overAntineoplastic AgentsCell Line, TumorColorectal NeoplasmsComprehensionCurriculumDNA Mutational AnalysisEducation, PharmacyFemaleGenetic Predisposition to DiseaseGenomicsHumansLearningMaleAntineoplastic AgentsBRAF protein, humanProto-Oncogene Proteins B-rafactive learningcancergenomicsoncologypharmacogenomicspharmacotherapy

Identifiers

PMID24761016
PMCPMC3996387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.